Pilot Pharmacokinetic Study of VAL-413 (Orotecan) in Patients with Recurrent Pediatric Solid Tumors
| Protocol No. | PHO-VALENT-VAL-10-001 | Scope | National |
|---|---|---|---|
| Principal Investigator | Kyle Jackson | Treatment Type | Treatment |
| Age Group | Children | Phase | NA |
PHO-VALENT-VAL-10-001
Contact information
Fernanda C. Rankin
fecarnev@iu.edu
